Showing results (171-180 of 186) with videos related to
Sort By:
Pageof 19
Frontiers in Oncology|December 24, 2019
Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic CancerChen-Yu Hu, Xiang-Ming Xu, Bo Hong, et al.Oncotarget|September 15, 2017
The lifecycle of the Ebola virus in host cellsDong-Shan Yu, Tian-Hao Weng, Xiao-Xin Wu, et al.Virology Journal|November 30, 2021
The viral distribution and pathological characteristics of BALB/c mice infected with highly pathogenic Influenza H7N9 virusXiao-Xin Wu, Song-Jia Tang, Shu-Hao Yao, et al.Molecular Pharmaceutics|June 27, 2018
Preclinical Efficacy of Anti-RON Antibody-Drug Conjugate Zt/g4-MMAE for Targeted Therapy of Pancreatic Cancer Overexpressing RON Receptor Tyrosine KinaseHang-Ping Yao, Liang Feng, Tian-Hao Weng, et al.Heliyon|April 1, 2024
Host proteins interact with viral elements and affect the life cycle of highly pathogenic avian influenza A virus H7N9Dong-Shan Yu, Xiao-Xin Wu, Tian-Hao Weng, et al.World Journal of Gastrointestinal Oncology|November 30, 2020
Pathological significance of abnormal recepteur d'origine nantais and programmed death ligand 1 expression in colorectal cancerYi-Zhi Liu, Da-Ting Han, Dan-Rong Shi, et al.Current Gene Therapy|December 2, 2016
Releasing of Herpes Simplex Virus Carrying NGF in Subarachnoid Space Promotes the Functional Repair in Spinal Cord Injured RatsZhi-Wei Chen, Hang-Ping Wang, Feng-Mei Yuan, et al.Cancer Research and Treatment|April 24, 2020
RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast CancerTian-Hao Weng, Min-Ya Yao, Xiang-Ming Xu, et al.Oncology Reports|January 28, 2015
Akt‑mediated phosphorylation of Oct4 is associated with the proliferation of stem‑like cancer cellsQing-Wei Zhao, Yan-Wen Zhou, Wen-Xin Li, et al.Journal for Immunotherapy of Cancer|March 16, 2019
Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapyHang-Ping Yao, Liang Feng, Sreedhar Reddy Suthe, et al.Pageof 19